Risk factors for surgical site infection following total joint arthroplasty

Journal of Bone and Joint Surgery - American Volume

Volumn 96, Issue 18, 2014, Pages e158(1)-

  Rasouli, Mohammad R ^a   Restrepo, Camilo ^a   Maltenfort, Mitchell G ^a   Purtill, James J ^a   Parvizi, Javad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTHROPLASTY; ARTICLE; CASE CONTROL STUDY; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; SURGICAL INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; COMORBIDITY; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; PREOPERATIVE CARE; REOPERATION; SEX DIFFERENCE;

ARTHROPLASTY, REPLACEMENT; COMORBIDITY; EPIDEMIOLOGIC METHODS; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; REOPERATION; SEX FACTORS; SURGICAL WOUND INFECTION;

EID: 84907284311     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.M.01363     Document Type: Article

References (23)

1. Namba RS, Inacio MC, Paxton EW. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am. 2013 May 1;95(9):775-82.
2. Merollini KM, Crawford RW, Whitehouse SL, Graves N. Surgical site infection prevention following total hip arthroplasty in Australia: a cost-effectiveness analysis. Am J Infect Control. 2013 Sep;41(9):803-9. Epub 2013 Feb 21.
3. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012 Sep;27(8) (Suppl):61-5: e1. Epub 2012 May 2.
4. Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect. 2008 Nov;70(Suppl 2): 3-10.
5. Lamarsalle L, Hunt B, Schauf M, Szwarcensztein K, Valentine WJ. Evaluating the clinical and economic burden of healthcare-associated infections during hospitalization for surgery in France. Epidemiol Infect. 2013 Dec;141(12):2473-82. Epub 2013 Feb 28.
6. Nero DC, Lipp MJ, Callahan MA. The financial impact of hospital-acquired conditions. J Health Care Finance. 2012 Spring;38(3):40-9.
7. Centers for Disease Control and Prevention. Surgical Site Infection (SSI) Event. http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf?agree= yes&next=Accept. 2014 Jan. Accessed 2014 Apr 7.
8. Barie PS. Surgical site infections: epidemiology and prevention. Surg Infect (Larchmt). 2002;3(Suppl 1):S9-21.
9. Namba RS, Inacio MC, Paxton EW. Risk factors associated with surgical site infection in 30,491 primary total hip replacements. J Bone Joint Surg Br. 2012 Oct;94(10):1330-8.
10. Song KH, Kim ES, Kim YK, Jin HY, Jeong SY, Kwak YG, Cho YK, Sung J, Lee YS, Oh HB, Kim TK, Koo KH, Kim EC, Kim JM, Choi TY, Kim HY, Choi HJ, Kim HB. Differences in the risk factors for surgical site infection between total hip arthroplasty and total knee arthroplasty in the Korean Nosocomial Infections Surveillance System (KONIS). Infect Control Hosp Epidemiol. 2012 Nov;33(11):1086-93. Epub 2012 Sep 24.
11. Chesney D, Sales J, Elton R, Brenkel IJ. Infection after knee arthroplasty a prospective study of 1509 cases. J Arthroplasty. 2008 Apr;23(3):355-9.
12. Cheadle WG. Risk factors for surgical site infection. Surg Infect (Larchmt). 2006;7(Suppl 1):S7-11.
13. Everhart JS, Altneu E, Calhoun JH. Medical comorbidities are independent preoperative risk factors for surgical infection after total joint arthroplasty. Clin Orthop Relat Res. 2013 Oct;471(10):3112-9.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
15. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004 Dec;57(12):1288-94.
16. Harrell FE Jr. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer-Verlag; 2010.
17. Rasouli MR, Maltenfort MG, Purtill JJ, Hozack WJ, Parvizi J. Has the rate of inhospital infections after total joint arthroplasty decreased? Clin Orthop Relat Res. 2013 Oct;471(10):3102-11.
18. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008 Jul;466(7):1710-5. Epub 2008 Apr 18.
19. Greenky M, Gandhi K, Pulido L, Restrepo C, Parvizi J. Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res. 2012 Oct;470(10):2695-701.
20. Park JH, Rasouli MR, Mortazavi SMJ, Tokarski AT, Maltenfort MG, Parvizi J. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am. 2013 Oct 2;95(19):1777-83.
21. Rasouli MR, Harandi AA, Adeli B, Purtill JJ, Parvizi J. Revision total knee arthroplasty: infection should be ruled out in all cases. J Arthroplasty. 2012 Jun;27(6):1239-43. e1-2. Epub 2012 Mar 3.
22. Beery TA. Sex differences in infection and sepsis. Crit Care Nurs Clin North Am. 2003 Mar;15(1):55-62.
23. Angele MK, Schwacha MG, Ayala A, Chaudry IH. Effect of gender and sex hormones on immune responses following shock. Shock. 2000 Aug;14(2):81-90.